MNMD Live signaler | Maksimer profitt med Getagraph.com

KJøP 117211 min ago

@ $4.45

Utstedt: 14 feb 2024 @ 18:00

Avkastning: 124.71%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: -4.40 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology...

Stats
Dagens volum	1.09M
Gjennomsnittsvolum	2.37M
Markedsverdi	705.01M
EPS	$0 ( 2024-05-02 )
Neste inntjeningsdato	( $-0.660 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.10
ATR14	$0.00800 (0.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Greenway Schond L.	Sell	5 560	Common Shares
2024-03-25	Karlin Dan	Sell	6 578	Common Shares
2024-03-25	Barrow Robert	Sell	16 519	Common Shares
2024-02-27	Wernli Miri Halperin	Buy	125 000	Stock Option (Right to Buy)
2024-02-27	Greenway Schond L.	Buy	150 000	Stock Option (Right to Buy)

INSIDER POWER
89.67
Last 96 transactions
Buy: 11 612 599 \| Sell: 348 471

Volum Korrelasjon

Lang: -0.09 (neutral)

Kort: 0.41 (neutral)

Signal:(55.194) Neutral

Mind Medicine (MindMed) Korrelasjon

10 Mest positive korrelasjoner
CRAI	0.975
DWAC	0.973
RNA	0.973
HEWG	0.969
NTRA	0.965
EBAY	0.965
ANIP	0.964
MSTR	0.963
XLRN	0.962
SHLD	0.96

10 Mest negative korrelasjoner
VORB	-0.966
PEAR	-0.959
LPSN	-0.946
BRQS	-0.946
CNXC	-0.941
TTEC	-0.94
TWKS	-0.94
UONEK	-0.94
QNRX	-0.939
VIOT	-0.939

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Mind Medicine (MindMed) Korrelasjon - Valuta/Råvare

-0.40
( neutral )

0.37
( neutral )

0.00
( neutral )

0.19
( neutral )

0.77
( moderate )

Mind Medicine (MindMed) Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-3.16M (0.00 %)
EPS:	$-2.44

FY	2023
Omsetning:	$0
Bruttogevinst:	$-3.16M (0.00 %)
EPS:	$-2.44

FY	2022
Omsetning:	$0
Bruttogevinst:	$-3.22M (0.00 %)
EPS:	$-1.530

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.14

Financial Reports:

No articles found.

Mind Medicine (MindMed)

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Sanntidsoppdatering for Mind Medicine (MindMed) [MNMD]

Upcoming Earnings Alert